The rising prevalence of genetic disorders owing to increasing maternal age is promoting applications of Non-Invasive Prenatal Testing (NIPT) for early detection in fetal stages. For instance, the risk of fetus having Down syndrome is about 1 in 1,250 for women who conceive at the age of 25. The risk increases to about 1 in 100 for women who conceive at the age of 40. Moreover, there are several agreements signed for the promotion of NIPT. For instance, in February 2018, Harvard Pilgrim signed a value-based contract with Illumina, Inc. to enable wider patient access to the next generation of noninvasive testing for the detection of prenatal genetic abnormalities. However, the complexities associated with Non-Invasive Prenatal Testing (NIPT) require trained professionals, which pose serious concern for growth of the market.
Major Key Players of the Non-Invasive Prenatal Testing (NIPT) Market are:
Illumina, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, QIAGEN, BGI, Agilent Technologies, Inc., Natera, Inc., YOURGENE HEALTH, CENTOGENE N.V., and PerkinElmer Inc., among others.
Non-Invasive Prenatal Testing involves replacing invasive testing methods, which pose serious risks to developing fetuses. Non-Invasive Prenatal Testing (NIPT) is an emerging technology, which can be performed within 9 weeks of pregnancy and involves no risk of miscarriage. In addition, it offers clinical benefits over existing prenatal screening tests, such as maternal serum screening (MSS), by detecting the presence of trisomy 21 (Down syndrome, DS) with high sensitivity (99.9%) and specificity (98%). Moreover, there are several campaigns and programs conducted to spread awareness regarding Non-Invasive Prenatal Testing (NIPT) for the early detection of genetic abnormalities. This, in turn, contributes to growth of the Non-Invasive Prenatal Testing market.
The Non-Invasive Prenatal Testing (NIPT) Market is segmented on the basis of Product Types, Method, Application and region.
Major Product Types of Non-Invasive Prenatal Testing (NIPT) Market covered are:
- Consumables
- Instruments
- Services
Major Methods of Non-Invasive Prenatal Testing (NIPT) Market covered are:
- Biochemical Screening Tests
- Ultrasound Detection
- Cell-Free DNA in Maternal Plasma Tests
- Fetal Cells in Maternal Blood Tests
Major Applications of Non-Invasive Prenatal Testing (NIPT) Market covered is:
- Trisomy
- Microdeletion Syndrome
No comments:
Post a Comment